相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Role of Antibodies in HIV Vaccines
John R. Mascola et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
GP41-Specific Antibody Blocks Cell-Free HIV Type 1 Transcytosis through Human Rectal Mucosa and Model Colonic Epithelium
Ruizhong Shen et al.
JOURNAL OF IMMUNOLOGY (2010)
Broadly Neutralizing Monoclonal Antibodies 2F5 and 4E10 Directed against the Human Immunodeficiency Virus Type 1 gp41 Membrane-Proximal External Region Protect against Mucosal Challenge by Simian-Human Immunodeficiency Virus SHIVBa-L
Ann J. Hessell et al.
JOURNAL OF VIROLOGY (2010)
Topological Layers in the HIV-1 gp120 Inner Domain Regulate gp41 Interaction and CD4-Triggered Conformational Transitions
Andres Finzi et al.
MOLECULAR CELL (2010)
Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals
Davide Corti et al.
PLOS ONE (2010)
Structure of HIV-1 gp120 with gp41-interactive region reveals layered envelope architecture and basis of conformational mobility
Marie Pancera et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
HIV sensitivity to neutralization is determined by target and virus producer cell properties
Axel M. Mann et al.
AIDS (2009)
HIV-1 Envelope Induces Memory B Cell Responses That Correlate with Plasma Antibody Levels after Envelope gp120 Protein Vaccination or HIV-1 Infection
Mattia Bonsignori et al.
JOURNAL OF IMMUNOLOGY (2009)
High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies
Hua-Xin Liao et al.
JOURNAL OF VIROLOGICAL METHODS (2009)
Correlation of Vaccine-Elicited Systemic and Mucosal Nonneutralizing Antibody Activities with Reduced Acute Viremia following Intrarectal Simian Immunodeficiency Virus SIVmac251 Challenge of Rhesus Macaques
Rachmat Hidajat et al.
JOURNAL OF VIROLOGY (2009)
Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals
Johannes F. Scheid et al.
NATURE (2009)
Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques
Ann J. Hessell et al.
NATURE MEDICINE (2009)
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Supachai Rerks-Ngarm et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
International Network for Comparison of HIV Neutralization Assays: The NeutNet Report
Eva Maria Fenyo et al.
PLOS ONE (2009)
Discordant memory B cell and circulating anti-Env antibody responses in HIV-1 infection
Yongjun Guan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
Laura M. Walker et al.
SCIENCE (2009)
The implications of patterns in HIV diversity for neutralizing antibody induction and susceptibility
Bette Korber et al.
CURRENT OPINION IN HIV AND AIDS (2009)
Fc receptor-mediated antiviral antibodies
Donald N. Forthal et al.
CURRENT OPINION IN HIV AND AIDS (2009)
Broadly Neutralizing Human Anti-HIV Antibody 2G12 Is Effective in Protection against Mucosal SHIV Challenge Even at Low Serum Neutralizing Titers
Ann J. Hessell et al.
PLOS PATHOGENS (2009)
The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus
Gunilla B. Karlsson Hedestam et al.
NATURE REVIEWS MICROBIOLOGY (2008)
Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination
Victoria R. Polonis et al.
VIROLOGY (2008)
Duration of humoral immunity to common viral and vaccine antigens
Ian J. Amanna et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Antibodies to CD4-induced sites in HIV gp120 correlate with the control of SHIV challenge in macaques vaccinated with subunit immunogens
Anthony DeVico et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Fc receptor but not complement binding is important in antibody protection against HIV
Ann J. Hessell et al.
NATURE (2007)
Virus glycosylation: role in virulence and immune interactions
David J. Vigerust et al.
TRENDS IN MICROBIOLOGY (2007)
Time dependence of protective post-exposure prophylax with human monoclonal antibodies against pathogenic SHIV challenge in newborn macaques
Flavia Ferrantelli et al.
VIROLOGY (2007)
Identifying epitopes of HIV-1 that induce protective antibodies
S Zolla-Pazner
NATURE REVIEWS IMMUNOLOGY (2004)
Transfer of neutralizing IgG to macaques 6 h but not 24 h after SHIV infection confers sterilizing protection: Implications for HIV-1 vaccine development
Y Nishimura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Rapid evolution of the neutralizing antibody response to HIV type 1 infection
DD Richman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Antibody neutralization and escape by HIV-1
XP Wei et al.
NATURE (2003)
Determination of a statistically valid neutralization titer in plasma that confers protection against simian-human immunodeficiency virus challenge following passive transfer of high-titered neutralizing antibodies
Y Nishimura et al.
JOURNAL OF VIROLOGY (2002)
Effector function activities of a panel of mutants of a broadly neutralizing antibody against human immunodeficiency virus type 1
M Hezareh et al.
JOURNAL OF VIROLOGY (2001)
Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro
PWHI Parren et al.
JOURNAL OF VIROLOGY (2001)
Passive immunization against oral AIDS virus transmission: An approach to prevent mother-to-infant HIV-1 transmission?
R Hofmann-Lehmann et al.
JOURNAL OF MEDICAL PRIMATOLOGY (2001)
Genetic subtypes, humoral immunity, and human immunodeficiency virus type 1 vaccine development
JP Moore et al.
JOURNAL OF VIROLOGY (2001)
Evolutionary and immunological implications of contemporary HIV-1 variation
B Korber et al.
BRITISH MEDICAL BULLETIN (2001)
Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies
JR Mascola et al.
NATURE MEDICINE (2000)
Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection
TW Baba et al.
NATURE MEDICINE (2000)
分享论文
